Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 119

Sort by

Sort Order Select

Journal Articles

Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia

Matteo Marchetti, Stefano Barelli, Maxime G. Zermatten, Fanny Monnin-Respen, Elena Matthey-Guirao, Nicole Nicolas, Francisco Gomez, Matthew Goodyer, Christiane Gerschheimer, Lorenzo Alberio

Blood (2020) 135 (14): 1171–1184.

https://doi.org/10.1182/blood.2019002845

Published: 2020

Includes: Supplemental data

Journal Articles

Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell Lymphoma

Diego Villa, MD MPH, Laurie H Sehn, MD, Kerry J Savage, BSc, MD MSc, Cynthia L Toze, MD FRCPC, Kevin Song, MD, Wendie L den Brok, Ciara L Freeman, MSc, MBBChir, David W. Scott, MBChB, PhD, Alina S Gerrie, MD MPH

Blood (2019) 134 (Supplement_1): 2814.

https://doi.org/10.1182/blood-2019-124217

Published: 2019

Journal Articles

Distinct Evolutionary Patterns in Chronic Lymphocytic Leukemia (CLL) during Resistance to Graft-Versus-Leukemia (GvL)

Blood (2019) 134 (Supplement_1): 516.

https://doi.org/10.1182/blood-2019-129520

Published: 2019

Journal Articles

Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include up-Regulated Innate Immune Modulators

Ahmad Faisal Karim, PhD, Anthony R. Soltis, PhD, Nadia P Ewing, MD, Clifton L. Dalgard, PhD, Matthew D. Wilkerson, PhD, Kathleen P. Pratt, PhD

Blood (2019) 134 (Supplement_1): 160.

https://doi.org/10.1182/blood-2019-124855

Published: 2019

Journal Articles

Tumor ADAM10/ADAM17-Mediated PD-L1 Loss May Predict Poor Outcomes in Diffuse Large B Cell Lymphoma

Jacob Orme, MD PhD, Jose Villasboas, MD, Haidong Dong, MD PhD

Blood (2019) 134 (Supplement_1): 4120.

https://doi.org/10.1182/blood-2019-124189

Published: 2019

Journal Articles

Platelet RNA Splicing Profiles Can Distinguish IgM MGUS Patients from Healthy Individuals

Mick J.M. Van Eijs, MSc, Nicolette C. Notermans, MD PhD, Tom Würdinger, PhD, Monique C. Minnema, MD PhD

Blood (2019) 134 (Supplement_1): 3771.

https://doi.org/10.1182/blood-2019-124325

Published: 2019

Journal Articles

Epichaperome Abundance Predicts Response to the Epichaperome Inhibitor, Puh-71, in Acute Myeloid Leukemia

Montreh Tavakkoli, MA,MD, Justin D. Kaner, MD, Sharma Sahil, PhD, Tony Taldone, PhD, Swathi Merugu, PhD, Gabriela Chiosis, PhD, Gail J. Roboz, MD, Monica L. Guzman, PhD

Blood (2019) 134 (Supplement_1): 5145.

https://doi.org/10.1182/blood-2019-125175

Published: 2019

Journal Articles

18F-Fluorodeoxyglucose Positron Emission Tomography Versus Bone Marrow Biopsy for the Evaluation of Bone Marrow Infiltration in Newly Diagnosed Lymphoma Patients: Real-World Clinical Management of Patients at the National Cancer Institute, México

Tania Aguado, MD, Antonio Olivas-Martinez, MD, Uvi Cancino-Ramos, MD, Diego Zúñiga, MD, Carmen Lome, MD, Silvia Rivas-Vera, MD, Myrna Candelaria, MD PharmD

Blood (2019) 134 (Supplement_1): 5813.

https://doi.org/10.1182/blood-2019-126231

Published: 2019

Journal Articles

Serum Citrulline As a Biomarker for Blood Stream Infections in Pediatric Hematopoietic Stem Cell Transplant Patients

Shyamli Singla, MD, Justin Wong, Shuang Jiang, Sarah Hussain, Laura Coughlin, Xiaowei Zhan, PhD, Andrew Y. Koh, MD

Blood (2019) 134 (Supplement_1): 3268.

https://doi.org/10.1182/blood-2019-127061

Published: 2019

Journal Articles

Predicting the Outcome in Egyptian Patients with Severe Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Matched Sibling Donors

Mai Aly, MD BSc, MS, Hassan Awada, MD, Douaa Sayed, MD, Esam ElBeih, MD, Raafat Abdel El Fattah, MD, Refat Fathy Abdel-Aal Naseer, MD, Reem Alagooz, MD, Rania Hafez, MD, Almetwaly M. Sultan, MD, Nahla El-Sharkawy, MD, Valeria Visconte, PhD, Reda Z. Mahfouz, MD PhD

Blood (2019) 134 (Supplement_1): 5652.

https://doi.org/10.1182/blood-2019-132183

Published: 2019

Journal Articles

Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial

Davine Hofste op Bruinink, MD MSc, Mark van Duin, PhD, Meral Beksac, MD, Christoph Driessen, MD, Heinz Ludwig, MD, Michael Vermeulen, BSc, Rowan Kuiper, MSc, Martin H van Vliet, PhD, Bronno van der Holt, PhD, Roman Hajek, MD PhD, Hans Erik Johnsen, MD Professor, Meletios A Dimopoulos, MD, Antonio Palumbo, MD, Michele Cavo, MD, Pieter Sonneveld, MD PhD

Blood (2018) 132 (Supplement 1): 3186.

https://doi.org/10.1182/blood-2018-99-119873

Published: 2018

Journal Articles

The Association between the Alpha-Fibrinogen Thr312Ala (rs6050) Polymorphism and Risk of Venous Thromboembolism Among Enrollees in the Gate Study

Amanda B Payne, MPH, PhD, Christine De Staercke, PhD, Joshua W Francis, PhD, Harland D. Austin, ScD, Kavita N Patel, MD MSc, Christopher J. Bean, PhD, W. Craig Hooper, PhD

Blood (2018) 132 (Supplement 1): 3803.

https://doi.org/10.1182/blood-2018-99-114670

Published: 2018

Journal Articles

The Brief Gah Scale (Geriatric Assessment in Hematology) Correlates Well with a Comprehensive Geriatric Assessment in Patients with Hematologic Malignancies

Raul Cordoba, MD PhD, Ana-Isabel Hormigo, MD, Javier Martinez-Peromingo, MD, Maria Jarana, RN, Marta Perez-Albacete, RN, Teresa Villaescusa, MD PhD, Elham Askari, MD, Jose Luiz Lopez Lorenzo, MD, Maria Angeles Perez-Saenz, MD PhD, Elena Prieto, MD, Maria Pilar Llamas Sillero, MD PhD

Blood (2018) 132 (Supplement 1): 4753.

https://doi.org/10.1182/blood-2018-99-116950

Published: 2018

Journal Articles

Differences in Protein S, Protein C, and Antithrombin Levels and Risk of Venous Thromboembolism Among American Black and White Enrollees in the Gate Study

Kavita N Patel, MDMSc, Amanda B Payne, MPH,PhD, Christopher J. Bean, PhD, W. Craig Hooper, PhD

Blood (2018) 132 (Supplement 1): 1224.

https://doi.org/10.1182/blood-2018-99-116314

Published: 2018

Journal Articles

Impact of Bone Marrow Biopsy on Risk Stratification of Low-Risk IgG MGUS Patients

Blood (2017) 130 (Supplement 1): 5397.

https://doi.org/10.1182/blood.V130.Suppl_1.5397.5397

Published: 2017

Journal Articles

Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism Is Associated with a Significant Decrease in Incidence of Bleeding Compared to Vitamin K Antagonists and Low-Molecular-Weight Heparins

Ameet Patel, MD, Hants Williams, PhD, Maria R. Baer, MD, Ann Butler Zimrin, MD, Jennie Y Law, MD

Blood (2017) 130 (Supplement 1): 978.

https://doi.org/10.1182/blood.V130.Suppl_1.978.978

Published: 2017

Journal Articles

Integrative Epigenetic and Single-Cell RNA-Seq Profiling of Human Hematopoietic Stem Cells Reveals Epigenetic Reprogramming of Enhancer and Regulatory Elements during Normal Aging

Emmalee Adelman, BA, André Olsson, MSc, PhD, Tingting Qin, PhD, R. Coleman Lindsley, MD PhD, Rafael Bejar, MD PhD, Nathan Salomonis, PhD, Lee Grimes, Maria E. Figueroa, MD

Blood (2017) 130 (Supplement 1): 770.

https://doi.org/10.1182/blood.V130.Suppl_1.770.770

Published: 2017

Journal Articles

Heparin Induced Thrombocytopenia: A Laboratory Comparison of the IgG Specific EIA Vs Polyspecific EIA

Rachel Leger, BAE, Deepti M. Warad, MD, Dong Chen, MD PhD, Rajiv K. Pruthi, MBBS

Blood (2017) 130 (Supplement 1): 3642.

https://doi.org/10.1182/blood.V130.Suppl_1.3642.3642

Published: 2017

Journal Articles

Prediction of Relapse Based on Remission ADAMTS13 Activity in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Camila Masias Castanon, MD, Clare Stevens, BS/CCRP, Lauren Jay, Haiwa Wu, Michael McGookey, Jian Chen, MD, James N. George, MD, Shangbin Yang, PhD, Spero R Cataland, MD

Blood (2017) 130 (Supplement 1): 4843.

https://doi.org/10.1182/blood.V130.Suppl_1.4843.4843

Published: 2017

Journal Articles

Composite Organ and Hematologic Response Model Risk Stratifies Patients with Light Chain Amyloidosis

Blood (2017) 130 (Supplement 1): 3046.

https://doi.org/10.1182/blood.V130.Suppl_1.3046.3046

Published: 2017

NARROW

Rapid and accurate Bayesian diagnosis of heparin-induced thrombocytopenia

Bendamustine and Rituximab As Induction Therapy in Both Transplant Eligible and Ineligible Patients with Mantle Cell Lymphoma

Distinct Evolutionary Patterns in Chronic Lymphocytic Leukemia (CLL) during Resistance to Graft-Versus-Leukemia (GvL)

Hemophilia A Inhibitor Subjects Show Unique PBMC Gene Expression Profiles That Include up-Regulated Innate Immune Modulators

Tumor ADAM10/ADAM17-Mediated PD-L1 Loss May Predict Poor Outcomes in Diffuse Large B Cell Lymphoma

Platelet RNA Splicing Profiles Can Distinguish IgM MGUS Patients from Healthy Individuals

Epichaperome Abundance Predicts Response to the Epichaperome Inhibitor, Puh-71, in Acute Myeloid Leukemia

18F-Fluorodeoxyglucose Positron Emission Tomography Versus Bone Marrow Biopsy for the Evaluation of Bone Marrow Infiltration in Newly Diagnosed Lymphoma Patients: Real-World Clinical Management of Patients at the National Cancer Institute, México

Serum Citrulline As a Biomarker for Blood Stream Infections in Pediatric Hematopoietic Stem Cell Transplant Patients

Predicting the Outcome in Egyptian Patients with Severe Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Matched Sibling Donors

Differential Effect of Upfront Intensification Treatment in Genetically Defined Myeloma Risk Groups - a Combined Analysis of ISS, Del17p and SKY92 Scores in the EMN-02/HOVON-95 MM Trial

The Association between the Alpha-Fibrinogen Thr312Ala (rs6050) Polymorphism and Risk of Venous Thromboembolism Among Enrollees in the Gate Study

The Brief Gah Scale (Geriatric Assessment in Hematology) Correlates Well with a Comprehensive Geriatric Assessment in Patients with Hematologic Malignancies

Differences in Protein S, Protein C, and Antithrombin Levels and Risk of Venous Thromboembolism Among American Black and White Enrollees in the Gate Study

Impact of Bone Marrow Biopsy on Risk Stratification of Low-Risk IgG MGUS Patients

Use of Direct Oral Anticoagulants in Patients with Sickle Cell Disease and Venous Thromboembolism Is Associated with a Significant Decrease in Incidence of Bleeding Compared to Vitamin K Antagonists and Low-Molecular-Weight Heparins

Integrative Epigenetic and Single-Cell RNA-Seq Profiling of Human Hematopoietic Stem Cells Reveals Epigenetic Reprogramming of Enhancer and Regulatory Elements during Normal Aging

Heparin Induced Thrombocytopenia: A Laboratory Comparison of the IgG Specific EIA Vs Polyspecific EIA

Prediction of Relapse Based on Remission ADAMTS13 Activity in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura

Composite Organ and Hematologic Response Model Risk Stratifies Patients with Light Chain Amyloidosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only